Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone vs Misoprostol for Cervical Preparation Prior to Procedural Abortion
NCT06502158Phase 1Recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Oct 2024
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mifepristone in induced abortion (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Percentage of participants achieving Intended dilation. Started Oct 2024; status: recruiting.
02
Drugs
mifepristone
03
Conditions
induced abortion
Beyond the preview
Go deeper on NCT06502158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06502158.